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Hoxa9 is a homeodomain transcription factor important for the generation of Flt3+hiIL-7R- lymphoid
biased-multipotential progenitors, Flt3+IL-7R+ common lymphoid progenitors (CLPs), and B cell precursors (BCP) in
bone marrow (BM). In addition to B-cell, Flt3+IL-7R+ CLPs possess NK and DC developmental potentials, although
DCs arise from Flt3+IL-7R- myeloid progenitors as well. In this study, we investigated the requirement for Hoxa9,
from Flt3+ or Flt3- progenitor subsets, in the development of NK and DC lineage cells in BM. Flt3+IL-7R+Ly6D- CLPs
and their Flt3+IL-7R+Ly6D+ B lineage-restricted progeny (BLP) were significantly reduced in hoxa9−/− mice.
Interestingly, the reduction in Flt3+IL-7R+ CLPs in hoxa9−/− mice had no impact on the generation of NK precursor
(NKP) subsets, the differentiation of NKP into mature NK cells, or NK homeostasis. Similarly, percentages and
numbers of common dendritic progenitors (CDP), as well as their plasmacytoid or conventional dendritic cell
progeny in hoxa9−/− mice were comparable to wildtype. These findings reveal distinct requirements for Hoxa9 or
Hoxa9/Flt3 molecular circuits in regulation of B versus NK and DC development in BM.
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Cell fate decisions in the hematopoietic system are contin-
gent upon the concerted activities of transcription factors
that activate and/or repress lineage specific developmental
programs and signaling molecules that regulate the tem-
poral expression and activation status of lineage instructing
regulatory proteins. Hoxa9 is a homeobox transcription
factor with key roles in embryogenesis, hematopoiesis, and
leukemogenesis [1]. Hoxa9 is highly expressed in primitive
blood cells in mouse and man, and downregulated as mul-
tipotent hematopoietic progenitors undergo lineage restric-
tion and commitment [2-4]. The nonredundant role of
Hoxa9 in hematopoietic progenitor biology has been deter-
mined through a variety of loss- and gain-of-function stra-
tegies. Hoxa9−/− mice are viable, but exhibit multiple
hematopoietic defects including impaired recovery from
hematopoietic stress, poor competitive reconstitution upon* Correspondence: medina.kay@mayo.edu
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reproduction in any medium, provided the ortransplantation, impaired responses to lineage determining
cytokines, and significant reductions in select LSK + sub-
sets, myeloid precursor subsets, common lymphoid pro-
genitors (CLP), thymic progenitors, and B cell precursors
(BCP) [5-7]. Hoxa9 regulates the hematopoietic progenitor
and BCP pool, in part, through transcriptional activation of
the gene encoding Flt3 [4]. The Flt3 signaling pathway is
critical for regulation of the hematopoietic progenitor pool
and is essential at various stages for B, DC, and NK deve-
lopment and/or homeostasis [4,8,9].
Downregulation of c-kit, the receptor for the hematopoietic
cytokine stem cell factor, accompanies lymphoid and DC
lineage restriction from Flt3+hi LMPP [10-12]. Lin-c-kit+lo
Flt3+ IL-7R+CLPs are a heterogeneous population that
exhibit B, NK, T, and DC lineage differentiation poten-
tials. Gene-targeted deletion of hoxa9 significantly
reduces numbers of Flt3+ IL-7R+CLPs and BCP in BM
[8,13-15]. NKP are also the progeny of Flt3+ IL-7R+
CLPs. Importantly, two independent groups using diffe-
rent experimental approaches recently showed thattd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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were IL-7R+, but Flt3-. In both studies, downregulation
of Flt3 and upregulation of CD122 (IL-15Rα) were se-
quential steps in NK commitment from Flt3+ IL-7R
+CLPs [16,17]. CD122 is a critical component of the
IL-15R complex and IL-15 signaling is essential for NK
development [18]. Lin-CD122+ NKP expressed high
levels of Id2, a transcription factor important for NK
differentiation [16]. Flt3 signaling has been suggested
to complement IL-15 in regulation of the BM NK cell
pool as well as NK homeostasis in the spleen [19]. At
present, there is no information regarding the conse-
quence of Hoxa9-deficiency, through Flt3-dependent or
Flt3-independent regulatory circuits, on NK commit-
ment, differentiation, or homeostasis.
Dendritic cells (DC) are essential innate immune effector
cells. DCs are generated in BM from both the myeloid and
lymphoid progenitor pathways. Common dendritic pro-
genitors (CDPs) originate from Flt3+ myeloid progenitors
that express Flt3+ but lack expression of the IL-7R [12].
IL-7R+Flt3+ CLP primarily give rise to plasmacytoid DC
[20]. Flt3 signaling is essential in regulation of DC develop-
ment in BM as well as DC homeostasis in the peripheral
lymphoid organs [9,12,21]. The Ets-family transcription
factor PU.1 regulates Flt3 in DCs [22]. Interestingly, a re-
cent study characterizing Hoxa9 target genes found many
Hoxa9 binding sites were also bound by PU.1, notably flt3
[23]. Therefore, a molecular contribution of Hoxa9 to the
development and/or homeostasis of DC lineage cells, mer-
its further investigation.
The goal of this study was to examine the role of Hoxa9
in regulation of NK and DC development and differenti-
ation. We found that, in contrast to B cells, Hoxa9 is
largely dispensable for the development or peripheral
homeostasis of NK or DC lineage cells. These findings un-
cover a distinct requirement for Hoxa9 in regulation of B
versus NK and DC development from Flt3+ MPPs.
Methods
Mice
C57Bl6 mice (8–16 weeks of age) were purchased from
The Jackson Laboratory (Bar Harbor, ME). Hoxa9−/−
and flt3l−/− mice have been described [4] and were bred
and maintained at the Mayo Clinic animal facility and
used between 8–16 weeks of age. All mice were aged
matched in individual experiments and the experimental
data did not vary as a function of age or sex. Bone mar-
row cells from individual male or female mice were col-
lected from the four hind limb bones after carbon
dioxide asphyxiation and single cell suspensions made in
preparation for flow cytometric analysis. All experiments
were carried out in accordance with Mayo Clinic Institu-
tional Animal Care and Use Committee guidelines under
Protocol A17509.Antibodies and flow cytometry
Methods for flow cytometry and progenitor isolation
have been extensively described [4,13]. Flow cytometric
analysis was performed on the FACS-Canto or LSRII
cytometers (BD Biosciences, San Jose, CA) and ana-
lyzed using FlowJo software (Tree Star, Ashland, OR).
All antibodies used in this study were purchased from
eBioscience, BioLegend, or Pharmingen. Antibody con-
jugations and combinations used to delineate progeni-
tor subsets were the following: ALP/BLP stain Lin+
cocktail (FITC conjugated CD45R/B220, CDllb/Mac1,
Ly6G/Gr1, TER119, CD3ε, CD8α, CD11c, NK1.1, Ly6C),
c-kit APCefluor 780, Sca1-PerCP Cy5.5, biotin IL-7R
(visualized with streptavidin PeCy7), Flt3 PE, and Ly6D
APC; NKP stain Lin+ cocktail (APC conjugated CDllb/
Mac1, CD3ε, NK1.1, CD19, Ly6D), biotin CD244 (visua-
lized with streptavidin PeCy7), CD27 APCefluor 780, IL-
7R PE, Flt3 PerCPefluor 710, and CD122 FITC; and CDP
stain Lin+ cocktail (FITC conjugated CD45R/B220, CDllb/
Mac1, Ly6G/Gr1, TER-119, CD3ε, CD8α, NK1.1), c-kit
APCefluor 780, Flt3-PE, bio-IL-7R (visualized with strepta-
vidin PeCy7), and CD115-APC; NK subsets, CD3ε PeCy7,
CD122 FITC, NK1.1 AF780, and Dx5 APC; DC subsets,
B220 AF780, MHCII APC, and CD11c PerCPCy5.5. All
flow cytometric analysis depicts progenitor subsets within
the lymphocyte light scatter gate (LLS) of BM (Figure 1A).
Statistics
Statistical significance was determined using the Student-t
test and p-values less than 0.05 were considered significant.
Results
Selective reduction in Flt3+IL-7R+, but not Flt3-IL-7R+CLPs
in hoxa9−/− mice
We previously showed that Lin-c-kitloIL-7R+Flt3+ CLPs are
significantly reduced in hoxa9−/− mice [4]. Lin-c-kitloFlt3+
IL-7R+cells can be fractionated into Flt3+IL-7R+Ly6D- all
lymphoid progenitors (ALP) and Flt3+IL-7R+Ly6D+B line-
age restricted progenitors (BLP) [24]. Therefore, we em-
ployed this flow cytometric analysis to further define the
lymphoid/B lineage developmental block in hoxa9−/− mice
[4,15]. The Lin+ cocktail used was extended to include anti-
bodies to CD11c, NK1.1, and Ly6C to eliminate contamin-
ation of CLPs with mature NK1.1+ NK or CD11c/Ly6C +
DCs. First, Lin-IL-7R+ cells within the lymphocyte light
scatter gate (Figure 1A) were gated for low expression of c-
kit (Figure 1B, gated region, middle panel). We note that
using the extended Lin+ cocktail and gating on IL-7R+ cells,
that overall percentages of Lin-IL-7R+ were not reduced in
hoxa9−/− mice (0.71 ± 0.20% vs. 0.83 ± 0.29% in hoxa9−/−
vs. wildtype, respectively, n = 5 mice). The Lin-IL-7R+c-kitlo
subset was then fractionated into ALP and BLP using diffe-
rential expression of Flt3 and Ly6D (Figure 1B, bottom
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Figure 1 Reduction in lymphoid progenitor subsets in hoxa9−/− mice. A) Lymphoid light scatter gate (LLS) used throughout these studies.
B) Flow cytometric analysis of BM Lin-IL-7R+c-kitlo CLP subsets in wildtype B6 and hoxa9−/− mice. The gating strategy is depicted from top to
bottom with arrows. The lineage cocktail includes antibodies to CD45R/B220, CDllb/Mac1, Ly6G/Gr1, TER119, CD3ε, CD8α, CD11c, NK1.1, and
Ly6C. Lin-IL-7R+ cells (top panel) were gated for IL-7R+c-kitlo cells (middle panel) and Lin-IL-7R+c-kitlo cells were fractionated into 3 subsets
based on differential expression of Flt3 and Ly6D. ALPs are gated as Lin-IL-7R+c-kitloFlt3+Ly6D- and BLP as Lin-IL-7R+c-kitloFlt3+Ly6D+. A third
Lin-IL-7R+c-kitloFlt3-Ly6D- subset is labeled as Flt3-Ly6D-. C) Summary of ALP, BLP, and Flt3-Ly6D- CLPs precursor frequencies in B6 (white bars)
and hoxa9−/− (gray bars) mice. Precursor frequencies were calculated by multiplying sequential percentages of each gated region (ie., % Lin-IL-
7R + in LLS gate x % ckitlo x %’s of ALP, BLP, or Flt3-Ly6D-). Data is representative of 5 individual B6 and hoxa9−/− animal BM analyses. The
asterisk indicates p < 0.05. Error bars represent SEM.
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reduced in hoxa9−/− mice, consistent with our previous
findings [4]. Precursor frequency analysis revealed that ALP
represent 0.061 ± 0.013% vs. 0.024 ± 0.01% of BM cells
within the lymphoid light scatter gate in B6 vs. hoxa9−/−
mice, respectively (p = 0.0009). Similarly, BLP represent
0.026 ± 0.002% vs. 0.01 ± 0.002% of BM cells within the
lymphoid light scatter gate in B6 vs. hoxa9−/− mice, re-
spectively (p = 0.0005). Less BLP resulted in reductions in
CD19+IgM- B cell precursors (11.5 ± 2% vs. 20.03 ± 2.0% of
BM cells within the lymphoid light scatter gate, p = 0.0009,
in hoxa9−/− vs. B6, respectively), consistent with our previ-
ous report [4,15]. In contrast, a conspicuous population of
IL-7R+Flt3-Ly6D- CLPs was not reduced (0.087 ± 0.22% vs.0.11 ± 0.06% of BM cells within the lymphoid light scatter
gate in B6 vs. hoxa9−/−mice, respectively, p = 0.11). Percen-
tages of ALP, BLP, and IL-7R+Flt3-Ly6D- CLPs in B6 con-
trol and hoxa9−/− mice are summarized in Figure 1C (data
represents mean and SEM). We conclude from these flow
cytometry analyses that Hoxa9-deficiency preferentially
reduces Flt3+IL-7R+, but not Flt3-IL-7R+ CLP subsets.
NK development and differentiation in hoxa9−/− mice
CD27+ and CD244+ are cell surface markers expressed
on IL-7R-Flt3+ multipotential progenitors (MPP) and
CLPs, and maintained on mature NK cells [25,26]. A
small subset of CD27+CD244+IL-7R+ progenitors were
identified in BM that lacked expression of surface
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sets, including CD19, Mac1, Ly6D, NK1.1, and CD3.
CD122 (IL-2Rβ) is a critical component of the IL-15R
complex (comprised of IL-15Rα, IL-2Rγ and IL-2Rβ)
[27]. Expression of the IL-15R is acquired as CLP diffe-
rentiate into NK cells and is associated with loss of B, T,
and DC lineage differentiation potentials. Fathman,
et al., evaluated NK precursor potential in Lin- (CD19-
Mac1- Ly6D- NK1.1- CD3-) CD27+CD244+IL-7R+ cells
[17]. Within the Lin-CD27+CD244+IL-7R+ subset, dif-
ferential expression of Flt3 and CD122 distinguished
three progenitor subsets, Flt3+CD122-, Flt3-CD122-,
and Flt3-CD122+. Transplantation studies revealed that
the Lin- CD27+CD244+ IL-7R+Flt3+ subset were found to
functionally largely overlap CLPs, while the Lin-CD27+ and
Lin-CD244+ subsets gave rise to NK cells. In vitro differen-
tiation studies confirmed that the Lin-CD27+CD244+
IL-7R+Flt3-CD122- and CD122+ subsets generated only
NK cells. Based on differential expression of CD122 and
the NK lineage bias exhibited by these cells in functional
assays, the Lin-CD27+CD244+IL-7R+Flt3-CD122- subset
was designated PreNKP and the Lin-CD27+CD244+IL-7R+
Flt3-CD122+ subset rNKP [17]. Previous studies showed
that loss of Flt3-L significantly reduced the mature BM
NK pool [9,19]. However, a role for Hoxa9, through Flt3
dependent or independent mechanisms, in regulation of
NK commitment and differentiation from the CLP stage
has not been determined.
We showed in Figure 1B-C that a subset of IL-7R+ CLPs
that lack Flt3- and Ly6D- are spared by Hoxa9-deficiency.
Since IL-7R+Flt3-Ly6D- CLPs are enriched for NK pre-
cursors we speculated that Hoxa9 might be dispensable
for NK commitment and differentiation from CLPs. To
make this determination, we employed the flow cyto-
metric analysis described above to examine the NK pre-
cursor compartment in hoxa9−/− mice. Consistent with
our findings in Figure 1B, percentages and absolute num-
bers of Lin- CD27+CD244+IL-7R+Flt3+ CLPs were sig-
nificantly reduced in hoxa9−/− mice (Figure 2A-C).
Importantly, shown in Figure 2A and summarized in
Figures 2B-C, neither frequencies nor numbers of PreNKP
or rNKP within the lymphoid light scatter gate in BM
were diminished by Hoxa9-deficiency. The reduction in
CLPs reinforces the requirement for Hoxa9 in regulation
of the IL-7R+Flt3+ CLP subset. Surprisingly, the reduction
in IL-7R+Flt3+ CLPs did not impact the generation or
maintenance of Pre-NKP or rNKP. These data suggest
that commitment to the NK fate is not dependent on
Hoxa9 function within CLPs.
Flt3 signaling has been implicated in regulation of the
mature BM NK compartment. Specifically, it was shown
that mature Lin-CD122+NK1.1+Dx5+ NK cells are
reduced in flt3l−/− mice and our results concur with
those findings (Figure 2D-E) [19]. Until the identificationof NKP, BM NK transitional subsets were distinguished by
differential expression of CD3ε, CD122, NK1.1, and
CD49b/Dx5 [28]. To determine whether Hoxa9 regulates
NK differentiation from NKP, BM cells from B6 wildtype,
hoxa9−/−, and flt3−/− mice were stained with antibodies
to CD3ε, CD122, NK1.1, and CD49b (Dx5) [28]. As shown
in Figure 2D-E, percentages and numbers of CD3ε-CD
122+NK1.1-Dx5- NKP and CD3ε-CD122+NK1.1+Dx5-
immature NK cells were similar between the 3 genotypes.
These results suggest that Hoxa9 is dispensable for NK
differentiation from rNKP. However, in contrast to Flt3
signaling, Hoxa9 is also dispensable for NK homeostasis
in BM and spleen as neither mature NK cell frequencies
nor numbers are reduced in BM or spleen in hoxa9−/−
mice (Figure 2D-G).
DC differentiation in hoxa9−/− mice
Lineage-restricted precursors of DCs are enriched within
Lin-ckit+loFlt3+ MPPs [12]. Flt3 signaling is essential for
DC differentiation and homeostasis [21,29]. Lineage-
restricted common dendritic progenitors CDP express
the CD115/M-CSFR, but lack expression of the lymphoid-
lineage-associated cytokine receptor IL-7R [12]. Lin-
ckit+loFlt3+ progenitors are reduced in hoxa9−/− mice
(Figure 3A, middle panel). However, percentages of
Lin-c-kit+lo Flt3+ cells expressing the CD115/M-CSFR
were comparable between wildtype and hoxa9−/− mice
(Figure 3A and summarized in Figure 3B). Next we com-
pared percentages and absolute numbers of DC-lineage
progeny. CD11c+MHCII+B220- conventional DC (cDC)
and CD11c+MHCII+B220+ plasmacytoid DC (pDC) are
the progeny of CDP, although there is experimental evi-
dence that DCs develop from CLP [20,29-31]. As shown
in Figure 4A-C, frequencies and absolute numbers of cDC
(gray bars) and pDC (white bars) in hoxa9- mice were
largely comparable to WT. Furthermore, percentages and
absolute numbers of cDC and pDC were also found at
comparable frequencies to B6 wildtype mice in the spleen
(data not shown). Consistent with previous findings, cDC
and pDC were reduced in BM and spleen of flt3l−/− ani-
mals (Figure 4B-C and data not shown) [9]. These data
suggest that Hoxa9 is not a critical component of the
regulatory circuitry that orchestrates DC commitment
and/or differentiation from Flt3+ MPPs.
Discussion
In this study we investigated the role of Hoxa9 in regula-
tion of NK- and DC-lineage commitment and differenti-
ation in BM. Hoxa9-deficient mice exhibit reductions in
select hematopoietic progenitor subsets, including Flt3+
MPPs, Flt3+IL-7R+ CLPs, myeloid progenitor subsets,
and BCPs, in addition to Pro-T subsets in the thymus
[4,15]. Hoxa9 regulates these hematopoietic progenitor



















































































































































Figure 2 Hoxa9 is dispensable for NK differentiation and homeostasis. A) BM cells from wildtype B6 or hoxa9−/− mice were isolated and
stained with combinations of antibodies as detailed in the Methods to resolve PreNKP and rNKP progenitor subsets. The Lin+ antibody cocktail
includes CDllb/Mac1, CD3ε, NK1.1, CD19, and Ly6D. The gating strategy is depicted from top to bottom with arrows. Data is representative of 6
individual mice of each genotype. B) NKP subset frequencies in BM of wildtype B6 (open bars) and hoxa9−/− (gray bars) mice. Precursor
frequencies reflect percentages of CLP, PreNKP, or rNKP within the Lin-CD244+CD27+IL-7R+ gated fractions. C) Absolute numbers of BM NKP
subsets in wildtype B6 (open bars) and hoxa9−/− (gray bars) mice. D) Summary of frequencies or E) absolute numbers of BM total CD3ε-CD122+
progenitors, NKP (CD3ε- CD122+NK1.1-Dx5-), immature NK (CD3ε-CD122+NK1.1+ Dx5-), and mature NK (CD3ε-CD122+NK1.1+ Dx5+) cells in
wildtype B6 (open bars), hoxa9−/− (light gray bars), and flt3l−/− (dark gray bars). Data reflects the average of each indicated subset pooled from
analysis of 7–8 mice per genotype. F) Flow cytometry profile of CD3ε- NK1.1+CD122+ NK cells in spleen. Spleen mononuclear cells were first
gated on CD3ε- (top panels). The CD3ε- splenocytes were then analyzed for expression NK1.1 and CD122 (bottom panels). G) Absolute numbers
of NK cells (CD3ε-NK1.1+CD122+) in spleen. Precursor frequencies were calculated by multiplying sequential percentages of each gated region as
described in Figure 1. Absolute numbers were determined by multiplying precursor frequencies x numbers of BM mononuclear cells obtained
from 4 hind limb leg bones. The asterisk indicates p < 0.05. Error bars represent SEM.
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and/or maintenance of Flt3+ MPPs, CLPs, B, T, NK, and
DC lineage cells [9,19]. Previously, a role for Hoxa9,
through Flt3-dependent or independent regulatory cir-
cuits, in regulation of NK- or DC-lineage commitment
and differentiation in BM had not been established. Here
we show that Hoxa9 is dispensable for the generation and
differentiation of NK and DC lineage cells in BM. In con-
trast, Hoxa9 plays a non-redundant role in regulation ofFlt3+IL-7R+ CLPs, as well as their Flt3+IL-7R+Ly6D+
B-lineage restricted progeny. Importantly, the reduction in
Flt3+IL-7R+ CLPs in hoxa9−/− mice does not comprom-
ise the generation of NKP. These findings distinguish a
critical function for Hoxa9 in Flt3+IL-7R+ CLPs in regula-
tion of B, but not NK lineage commitment.
The differentiation of DC lineage cells from multipo-
tent hematopoietic progenitors is driven by the com-





























Figure 3 Hoxa9 is dispensable for the development of CDP in BM. A) Flow cytometry profile of CDP in B6 and hoxa9−/− mice. The Lin+
antibody cocktail included CD45R/B220, CDllb/Mac1, Ly6G/Gr1, TER-119, CD3ε, CD8α, and NK1.1. The gating strategy is depicted from top to bottom
with arrows. CDP are identified as Lin-ckitloFlt3+ CD115/M-CSFR+. B) CDP precursor frequency. Precursor frequencies were calculated by multiplying
sequential percentages of each gated region as described in Figure 1. Data is representative of 4 individual mice per genotype. Error bars represent SEM.
Gwin et al. BMC Immunology 2013, 14:5 Page 6 of 9
http://www.biomedcentral.com/1471-2172/14/5and GM-CSF [32]. Importantly, DCs develop from both
myeloid and lymphoid precursors. Myeloid progenitors
are minimally affected by Hoxa9-deficiency, thus provi-
ding an alternate route for DC production [6]. Although
Hoxa9 is a critical regulator of flt3, Flt3 is expressed, al-
beit at lower levels, in Hoxa9-deficient hematopoietic
progenitors [4]. In addition to Hoxa9, the Ets-family
transcription factor PU.1 is a key regulator of flt3. It was
previously established that PU.1 regulation of Flt3 is es-
sential for DC development [22]. Hoxa9 transcripts are
low/negative in CDP and Macrophage Dendritic Pro-
genitors (MDP), compared to Flt3+ MPP or CLPs. In
contrast, PU.1 transcripts are elevated in CDP and MDP
(Figure 5) [33]. Hierarchically, MDP give rise to CDP,
and CDP are the lineage restricted precursors of conven-
tional and plasmacytoid dendritic cells [34]. Interes-
tingly, MDP numbers are not reduced in flt3−/− mice,
suggesting that Flt3 expression is not required for com-
mitment to the DC fate [21]. Our data extend these
results and establish that Hoxa9 function is dispensable
for commitment and differentiation in the DC lineage.
A recent fate mapping study of an IL-7R reporter
mouse suggested that all NK-lineage cells progress
through an IL-7R + stage [35]. IL-7R + hematopoieticprogenitors are generated in flt3−/− and flt3l−/− mice,
albeit at reduced frequencies [8,13]. Thus, Flt3 signaling
is not essential for induction of IL-7R expression, con-
sistent with our current findings. CD122 is upregulated
in Flt3- CLPs uncoupling Flt3 signaling from induction
of CD122 expression. PreNKP have been proposed to be
developmentally positioned downstream of Flt3+ IL-7R+
CLPs (Figure 5). We note that the few B220+ cells iden-
tified in FL−/− x IL-7Ra−/− mice are NK1.1+ [36]. Fur-
thermore, il7−/− mice exhibit no deficiencies in NK
cells in BM [19,37]. These experimental results together
with our findings herein suggest that commitment to the
NK fate is not dependent on the combinatorial activities
of Flt3 and/or IL-7R signaling or Hoxa9 function.
We show significantly reduced percentages of Flt3+IL-
7R+ CLP/ALPs and Flt3+IL-7R+ BLPs in hoxa9−/− mice.
The combinatorial activities of Flt3 and IL-7R signaling
are indispensable for B cell genesis [36]. IL-7R signaling in
CLPs promotes the generation of BLP and their subse-
quent differentiation into BCP through Stat5-mediated
induction of the B-cell fate determinant EBF [38,39]. EBF
in turn suppresses Id2 transcription [40,41]. Id2 is critical
for NK differentiation and transcript levels are increased
in IL-7R+Flt3- rNKP [16,42-44]. The observation that













































































Figure 4 Hoxa9 is not required for DC differentiation. A) Flow cytometric comparison of DC subsets in BM of wildtype B6, flt3l−/−, and
hoxa9−/− mice. BM cells were first analyzed for MHCII expression. The MHCII + cells were then fractionated based on differential expression of
CD45R/B220 into MHCII+B220+ or MHCII+B220-. Conventional DCs are MHCII+B220-CD11c+. Plasmacytoid DCs are MHCII+B220+ CD11c+. B) pDC
(white bars) and cDC (gray bars) precursor frequency in BM. C) Absolute numbers of pDC (white bars) and cDC (gray bars) in BM. Precursor
frequencies were calculated by multiplying sequential percentages of each gated region as described in Figure 1. Absolute numbers were
determined by multiplying precursor frequencies x numbers of BM mononuclear cells obtained from 4 hind limb leg bones. Data is
representative of 4 mice per genotype. Error bars represent SEM.






























































Figure 5 Model depicting Hoxa9 and Flt3 expression patterns in DC, NK, and B cell precursors in BM. HSC, MPP, GMLP and LMPP are
primitive LSK+ subsets defined by differential expression of Flt3 and VCAM-1 [46]. CLP are Lin-ckitloIL-7R+Flt3+Ly6D-. BLPs are a B lineage
restricted subset of CLP/ALP that express Ly6D. ProB through PreB are B220+ B cell progenitor subsets. PreNKP are Lin-CD244+CD27+IL-7R+Flt3-
loCD122- and are the presumed progeny of CLP/ALP. rNKP through mNK are NK lineage restricted subsets distinguish based on expression of
CD122, NK1.1 and Dx5. Hoxa9 and Flt3 expression patterns within the subsets are derived from our previous study [4], or deduced from the
Immunological Genomic Project database (http://www.immgen.org/databrowser/index.html).
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tially unchanged while BLP are reduced suggest that
Hoxa9, alone or in combination with Flt3 signaling, regu-
lates a critical molecular circuitry that dictates the B vs.
NK fate decision in Flt3+IL-7R+ CLP/ALPs.
Finally, the dramatic downregulation of Flt3 in PreNKP
suggests that commitment to the NK fate might initiate a
series of events that silences flt3 expression. Induction of
the B lineage commitment factor Pax5 silences Flt3 tran-
scription in committed BCP [45]. Interestingly, failure to
downregulate Flt3 impairs B cell differentiation. Ectopic
expression studies examining the consequences of sus-
tained expression of Flt3 or Hoxa9 on NK differentiation
will be informative with regard to the requirement for
regulated expression of Flt3 or Hoxa9 in NK development.
Conclusion
In summary, Hoxa9 is a critical regulator of early
hematopoietic differentiation, in part through regulation
of Flt3. We uncovered differential requirements for a
Hoxa9 in the development/maintenance of IL-7R+Flt3+
CLPs and BLP. Although NKP and CDP share a com-
mon Lin-c-kitloFlt3+ progenitor with BLP, Hoxa9 is dis-
pensable for their development and differentiation.
These findings reinforce the stringent requirement for
Hoxa9 in regulation of B lymphopoiesis and support fu-
ture studies aimed at delineating Hoxa9-dependent gene-
tic circuits that dictate the B cell fate decision.Abbreviations
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